/
Looking under the streetlight? Looking under the streetlight?

Looking under the streetlight? - PowerPoint Presentation

briana-ranney
briana-ranney . @briana-ranney
Follow
367 views
Uploaded On 2017-11-09

Looking under the streetlight? - PPT Presentation

Understanding delays and TB transmission Nim Arinaminpathy Imperial College London IDM Symposium 20 Apr 2017 Tuberculosis today 2 An estimated 96 million cases of TB occurred globally in 2014 ID: 603883

care treatment risk delay treatment care delay risk relapse cure seeking patient quality diagnostic private prevalence disease public transmission

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Looking under the streetlight?" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Looking under the streetlight?

Understanding delays and TB transmission

Nim

Arinaminpathy

Imperial College London

IDM Symposium

, 20

Apr 2017Slide2

Tuberculosis today

2

An estimated 9.6 million cases of TB occurred globally in 201425% of this burden occurred in India alone, the highest of any countryGlobal Tuberculosis Report, 2015Slide3

End TB StrategySlide4

4

At present No transmission-blocking vaccine

, but cost effective chemotherapySlide5

We need to understand where transmission is happeningSlide6

TB control in India: a brief retrospective

DOTS: treatment outcomes and case detectionPublic-sector services (Revised National TB Control Programme) scaled up from 1997

But problems remainVast and unregulated private sector2012 NSP: “The extension of RNTCP services to patients diagnosed and treated in the private sector”Slide7

A possible mechanism

Public-Private Interface Agency (PPIA)Pilot PPM scheme funded by Bill and Melinda Gates FoundationEngage with private providers, incentivising to improve:Quality of TB diagnosisNotification to public sectorTreatment outcomes

Financial incentives vs Training and engagementSlide8

The settingSlide9

The setting

What is the potential epidemiological impact of a PPIA at scale?Slide10

Uninfected

Latent

infection

Active disease,

Pre-care-seeking

βI

d

Treatment

initiation

Treatment

c

ompletion

Cure, HIGH

relapse risk

Cure, LOW

relapse risk

(Default)

(Success)

Patient

delay

Diagnostic

delay

Quality of

TB treatmentSlide11

Uninfected

Latent

infection

Active disease,

Pre-care-seeking

βI

d

Treatment

initiation

Treatment

c

ompletion

Cure, HIGH

relapse risk

Cure, LOW

relapse risk

(Default)

(Success)

Patient

delay

Diagnostic

delay

Quality of

TB treatment

Pathway

surveysSlide12

Key data inputsSlide13

Uninfected

Latent

infection

Active disease,

Pre-care-seeking

βI

d

Treatment

initiation

Treatment

c

ompletion

Cure, HIGH

relapse risk

Cure, LOW

relapse risk

(Default)

(Success)

Patient

delay

Diagnostic

delay

Quality of

TB treatment

ARTI,

Prevalence

Pathway

surveysSlide14

Potential epidemiological impact

Arinaminpathy et al, In prepSlide15

Uninfected

Latent

infection

Active disease,

Pre-care-seeking

βI

d

Treatment

initiation

Treatment

c

ompletion

Cure, HIGH

relapse risk

Cure, LOW

relapse risk

(Default)

(Success)

Patient

delay

Diagnostic

delay

Quality of

TB treatmentSlide16

Uninfected

Latent

infection

Active disease,

Pre-care-seeking

βI

d

Treatment

initiation

Treatment

c

ompletion

Cure, HIGH

relapse risk

Cure, LOW

relapse risk

(Default)

(Success)

Patient

delay

Diagnostic

delay

Quality of

TB treatment

~ 1 – 2 months

(reported)Slide17

Uninfected

Latent

infection

Active disease,

Pre-care-seeking

βI

d

Treatment

initiation

Treatment

c

ompletion

Cure, HIGH

relapse risk

Cure, LOW

relapse risk

(Default)

(Success)

Patient

delay

Diagnostic

delay

Quality of

TB treatment

~ 1 – 2 months

(reported)

~

4 – 5 months

(fitted)

M.A.N.E.Slide18

What the data suggests (i)Slide19

What the data suggests (ii)

19

Gujarat prevalence survey

, 2011Slide20

What the data suggests (ii)

Gujarat prevalence survey, 2011

Courtesy of

Dr

Kiran

Rade

,

Central

TB DivisionSlide21

We need to understand where transmission is happeningSlide22

Chest

symptomatics seeking careSlide23

Chest

symptomatics seeking care

Key burden indicators(ARTI

etc

)

Cross-sectional (prevalence) surveysSlide24

Chest

symptomatics seeking care

Some TB cases never contacting the healthcare system?

Most patients wait for several months before seeking care?

Key burden indicators

(ARTI

etc

)

Cross-sectional (prevalence) surveysSlide25

We may be missing transmission as long as we’re missing the sociological perspective

Increasing awareness?Addressing stigma?Lowering barriers to care?

What would be the impact on TB incidence?

Is there evidence that TB patients defer

careseeking

?

Upcoming work with NIRT (Chennai), FMR (Mumbai)

Also evidence

from other prevalence surveys in the

region

Ongoing

work: modelling TB in

WHO/SEARO

What is going on?Slide26

India’s next National Strategic Plan

…but more ‘real’ evidence now needed...Slide27

Thank youSlide28

Spare slidesSlide29

Many reasons for engaging the private sector

Surveillance: India’s public TB programme covers only estimated ~60% of TB casesBurden of TB managed by the private sector is much higher than previously recognised (Arinaminpathy et al, 2016)Extending public-sector quality of care to the private sector

’Saving lives’ through improved outcomesFree TB drugs and adherence supportReducing opportunities for transmission ….?

Not without demand generationSlide30

Movement in a fragmented healthcare system

Kapoor, Raman,

Sachdeva, Satyanarayana (2012) PLoS ONE

30Slide31

FQ

LTFQ

Chemist

Public

FQ

LTFQ

Chemist

Public

Mumbai

Patna

Aside: fresh views on

patient pathways

Arinaminpathy

et al, In prepSlide32

Gujarat prevalence survey

Mumbai model, cross-sectionNot yet visited a provider

69%36%Have sought care, but not on treatment

17%

21%

Have sought care, been diagnosed, and

on treatment

11%

42%

Of microbiologically positive TB

What the data suggests (ii)

Patient delay

Diagnostic delaySlide33

Increasing awareness?

Addressing stigma?What are the barriers to patient careseeking?And how might they be addressed?

What would be the impact on TB incidence?Demand generation: what does it mean?Slide34

What the data suggests (i)

Early TB symptoms are too subtle for patients to report

Diagnosed patients are ‘telling the truth’: there is another population that never access care

Of several

careseeking

episodes, only the most recent is reported

Related Contents


Next Show more